CARM icon

Carisma Therapeutics
CARM

Overview Fund Activity

25 hedge funds and large institutions have $8.34M invested in Carisma Therapeutics in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
4
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FV2GP
1
Flagship Ventures 2007 General Partner
Massachusetts
$3.2M
2
FVFIGP
2
Flagship Ventures Fund IV General Partner
Massachusetts
$2.46M
3
BC
3
Boxer Capital
California
$1.67M
4
VKH
4
Virtu KCG Holdings
New York
$55K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$45K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
BFA
2
BlackRock Fund Advisors
California
$3K
3
Goldman Sachs
3
Goldman Sachs
New York
$22K
4
BCM
4
Bridgeway Capital Management
Texas
$0
5
UBS Group
5
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BIM
26
BlackRock Investment Management
Delaware
– – -1,793 Closed
AIG
27
American International Group
New York
– – -250 Closed
RFA
28
Reilly Financial Advisors
California
$0 100 – –
Bank of America
29
Bank of America
North Carolina
$0 35 +35 New
AG
30
Advisor Group
Arizona
$0 250 +250 New
CG
31
Cutler Group
California
$0 300 +300 New
1
2